Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patients
AUTOR(ES)
Brites, C, Goyanna, F, França, LG, Pedroso, C, Netto, EM, Adriano, S, Sampaio, J, Harrington Jr, W
FONTE
Brazilian Journal of Infectious Diseases
DATA DE PUBLICAÇÃO
2011-02
RESUMO
OBJECTIVE: To compare the clinical characteristics and outcomes of HIV-1-HTLV-1 coinfected patients, in Bahia, Brazil. METHODS: Retrospective, comparative study. RESULTS: Among a total of 123 consecutive HIV infected patients, 20 men (20.6%) and 6 women (23.1%) had detectable antibodies against HTLV-I/II. The major risk factor associated with coinfection by HTLV was intravenous drug use (57.7% of coinfected patient versus 9.2% of HTLV seronegative patients, p < 0.0001). Coinfected patients had higher absolute lymphocyte counts (1,921 + 762 versus 1,587 + 951, p = 0.03). Both groups of patients had similar means of CD4+ and CD8+ cell counts. However, among patients with AIDS CD4+ cell counts were significantly higher among those coinfected with HTLV-I/II (292 ± 92 cells/mm³, versus 140 ± 177cells/mm³, p = 0.36). The frequency and type of opportunistic infections were similar for both groups, but strongyloidiasis and encephalopathy were more frequently diagnosed in coinfected patients (p < 0.05). On the other hand, patients coinfected with HTLV-I/II received significantly less antiretroviral therapy than singly infected by HIV-1. CONCLUSION: Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis for HIV patients. Higher CD4 count may lead to underestimation of immunodeficiency, and delay to initiate antiretroviral therapy.
Documentos Relacionados
- Biomolecular study of seroindeterminate individuals for the retrovirus HTLV-I/II
- HTLV-I/II associated disease in England and Wales, 1993-7: retrospective review of serology requests
- Infecção por HTLV-I/II e doenças do tecido conjuntivo
- HTLV-I/II seroprevalence and risk factors in pregnant women treated at primary health units in the municipality of Botucatu
- Prevalence and Risk factors of HTLV-I/II in a cohort of patients with HIV-1 infection in two cities from the state of São Paulo, Brazil